Identifying Failure Predictors in Thyroid Nodule Radiofrequency Ablation Using Multivariate Analysis: A Single‐Centre Experience
Open Access
- 8 March 2026
- journal article
- Published by Wiley in Clinical Endocrinology
- Vol. 105 (1) , 85-92
Abstract
Background: Radiofrequency ablation (RFA) has become an established minimally invasive treatment for benign thyroid nodules (BTN), offering excellent safety and efficacy. However, factors predicting treatment success and post‐procedural thyroid dysfunction remain incompletely understood. This study aimed to perform a preliminary evaluation of clinical, procedural, and biochemical predictors of RFA outcomes in a real‐world consecutive patient cohort. Study Design and Methods: A retrospective analysis was conducted on consecutive patients who underwent ultrasound‐guided RFA for cytologically benign thyroid nodules between January 2018 and March 2024 at a single tertiary medical centre. Demographic, sonographic, procedural, and biochemical variables, including thyroid‐stimulating hormone (TSH), thyroglobulin (Tg), and anti‐Tg antibodies, were analysed. The primary endpoint was the Volume Reduction Ratio (VRR), with ≥ 50% defined as procedural success. Results: Sixty‐two patients (mean age 52.6 years; 85.5% female) were included. The median best VRR achieved was 61.9% (IQR 46.6–74.5), with 71% of patients attaining ≥ 50% reduction. Higher pre‐treatment Tg levels were significantly associated with reduced VRR ( p < 0.001) and remained independently associated with procedural failure in an exploratory multivariable model (OR 0.87 per 10 ng/mL increase, p = 0.011). Pretreatment TSH levels showed a univariate positive trend but did not reach statistical significance on multivariate analysis. Two patients (3.2%) developed hypothyroidism post‐RFA, both with positive anti‐Tg antibodies (total 13 patients had positive anti Tg Ab). The overall complication rate was 6.5%, with no major adverse events. Conclusions: Our results suggest that pre‐treatment thyroglobulin levels may serve as a potential biochemical predictor of RFA success in benign thyroid nodules, while antibody positivity may suggest susceptibility to post‐ablation hypothyroidism. While most existing literature focuses on imaging features (e.g., sonographic features) or surgeon technique, our findings highlight the unique importance of biochemical characteristics. Incorporating biochemical profiling into pre‐procedural assessment could refine patient selection and enhance individualised treatment planning. Future prospective studies are warranted to validate Tg as a biomarker of RFA response.Keywords
This publication has 27 references indexed in Scilit:
- Radiofrequency ablation of benign thyroid nodules: A prospective, multi-institutional North American experienceSurgery, 2023
- Can Thyroid Nodules be Managed with Radiofrequency Ablation?Advances in Surgery, 2023
- Efficacy of radiofrequency and laser thermal ablation in solving thyroid nodule-related symptoms and cosmetic concerns. A systematic review and meta-analysisReviews in Endocrine and Metabolic Disorders, 2022
- Radiofrequency ablation and related ultrasound-guided ablation technologies for treatment of benign and malignant thyroid disease: An international multidisciplinary consensus statement of the American Head and Neck Society Endocrine Surgery Section with the Asia Pacific Society of Thyroid Surgery, Associazione Medici Endocrinologi, British Association of Endocrine and Thyroid Surgeons, European Thyroid Association, Italian Society of Endocrine Surgery Units, Korean Society of Thyroid Radiology, Latin American Thyroid Society, and Thyroid Nodules Therapies AssociationHead & Neck, 2021
- Radiofrequency ablation and thyroid nodules: updated systematic reviewEndocrine, 2021
- Radiofrequency Ablation for Benign Thyroid Nodules: 1‐Year Follow‐Up in 184 PatientsWorld Journal of Surgery, 2019
- Epidemiology of thyroid nodulesBest Practice & Research Clinical Endocrinology & Metabolism, 2008
- In vitro assays to test the interference of anti-thyroglobulin antibodies on thyroglobulin measurementEndocrine, 2008
- Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patientsEuropean Radiology, 2008
- Thyroglobulin regulates follicular function and heterogeneity by suppressing thyroid-specific gene expressionBiochimie, 1999